![Michael Bailey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 467 640 $ in data 31/05/2026
Michael P.
Bailey is currently President, Chief Executive Officer & Director at AVEO Pharmaceuticals, Inc. since 2010.
He is Chairman at IMV, Inc. since 2022 and Director at Verastem, Inc. starting in 2026.
Formerly, Mr. Bailey was a Member of Global Commercial Partnership Teams at Genentech, Inc., Senior Vice President-Commercial Operations at ImClone LLC from 1999 to 2008, and Chief Commercial Officer & Senior Vice President at Synta Pharmaceuticals Corp.
from 2008 to 2010.
Education includes undergraduate studies at St. Lawrence University and an MBA from Mendoza College of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VERASTEM, INC. 0,18% | 21/05/2026 | 108.000 ( 0,18% ) | 467 640 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Amministratore Delegato | 06/01/2015 |
| IMV INC. | Presidente | 01/05/2022 |
| VERASTEM, INC. | Direttore/Membro del Consiglio | 26/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Corporate Officer/Principal | 07/09/2010 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01/08/2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Mendoza College of Business
 Mendoza College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
